Ltr Pharma Limited has released a press release.
SPONTAN Real-World Study Reports 93% Response
Earlier from Ltr Pharma
- LTR Executes U.S. Commercial Agreement with Strive
- LTR Executes Definitive U.S. Commercial Agreement with Shed
- Response to ASX Aware Letter
- LTR Secures Exclusive U.S. Pharmacy Partner for ROXUS